HLA class I and leukemia association in mestizo patients from Zulia state, Venezuela;Asociación HLA clase I y leucemia en pacientes mestizos del estado Zulia, enezuela

Investigacion Clinica

Volumn 44, Issue 4, 2003, Pages 283-289

  Villalobos, Carmen Cecilia ^a,c   Rivera, Sergio ^a,b   Weir Medina, Jesús ^a,b   Hassanhi, Manzur ^a,b   Montiel, Milagros ^a   González, Romer ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b Instituto Hematologico de Occidente   (Venezuela)

^c NONE   (Venezuela)

Author keywords

HLA; Leukemia; PCR SSP; RR

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHI SQUARE TEST; CHILD; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FISHER EXACT TEST; GENE FREQUENCY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESTIZO; POLYMERASE CHAIN REACTION;

EID: 0842264902     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. a edición. Barcelona (España): Ediciones Harcourt; 2001. P 345-346.
2. Lilly F. The influence of H-2 type on gross leukemogenesis in mice. Transplant Proc 1971; 3:1239-1241
3. Lilly F, Boyse EA, Oid LJ. Genetic basis of susceptibility to viral leukaemogenesis. Lancet 1964; 2:1207-1209.
4. Lilly F. The inheritance of susceptibility to the gross leukemia virus in mice. Genetics 1966; 53:529-539.
5. Robinson D, Nepom G. The human major histocompatibility complex and disease susceptibility. Immunol Al Clin N American 1993; 13(2):255-272.
6. Schlosstein L, D. M, Terasaki P, Bluestone R, Pearson C. High association of an HLA antigen, W27, with Ankylosing Spondylitis. N Eng J Med 1973; 288(14): 704-706.
7. Au W, Hawkins B, Cheng N, Líe A, Liang R, Kwong Y. Risk of haematological malignancies in HLA-B27 carriers. Br J Haematol 2001; 115:320-322.
8. Arce S, Inda R, Morera L, Ustariz C, Ballester J. Frecuencia fenotípica y génica de antígenos HLA en la Miastenia gravis. Rev Neurol 1980; 34:27-32.
9. Bach J. Organ-specific autoimmunity. Immunol Today 1995; 16(7):353-355.
10. Nepom B. The role of the mayor histocompatibility complex in autoimmunity: Clin Immunol Immunopathol 1993; 67(3):50-55.
11. Dausset J. The major histocompatibility complex in man. Science 1981; 213:1469-1474.
12. Blank M, Blank M, King S, Yashiki S, Kuwayama M, Fujiyama C, Gongora D, Zaninovic V, Cranston B, Hanchard B, Imanishi T, Manns A, Blattner WA, Tajima K, Hayami M, Fuyiyoshi T, Sonoda T. Distribution of HLA and haplotypes of Colombian and Jamaican black populations. Tissue Antigens 1995; 45:111-116
13. Bunce M, O'neill C, Bernardo M, Krausa P, Browning M, Morris P, Welsh K. Phototyping comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mix utilizing sequence-specific primer (PCR-SSP). Tissue Antigens 1995; 46:355-367.
14. Dieye A, Diaw M, Rogier C, Trape J, Sarthou J. HLA-A, -B, -C, -DR, -DQ typing in a population group of Senegal: distribution of HLA antigens and HLA-DRB1*13 and DRB1*11 subtyping by PCR using sequence-specific primer (PCR-SSP). Tissue Antigens 1996; 47:194-199.
15. Hashimoto M, Kinoshita T, Yamasaki M, Hidenori T, Imanishi T, Ihora H, Ichikawa Y, Fukunishi T. Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals. Tissue Antigens 1994; 44:166-173.
16. Makhatadze N, Franco M, Layrisse Z. HLA cass I and class II allele and haplotype distribution in the Venezuelan population. Hum Immunol 1997; 55:53-58.
17. Bene MC, Castoldi G, Knapp W, Ludwing WD, Matutes E, Orfao A. European group for the immunological characterization of leukaemia (EGIL). Proposals for the inmunological classification of acute leukaemia. Leucemia 1995; 9:1783-1786.
18. Gorodezky C, Alaez C, Vásquez M, Infante E, Balladares S, Moreno M, Olivo A, Debaz H, Hernandez A. Manual de Procedimientos de Genética Molecular. Mexico, 2000.
19. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988,16(3):1215
20. Pineda B.L. Genética de Poblaciones: Problemario. Maestría en Genética. Facultad de Medicina. Universidad del Zulia. 1999.
21. Hilliard Festenstein and Peter Démant. HLA and H-2. Basic Immunogenetics, Biology and Clinical Relevance. Edward Arnold. 1978.p25-29.
22. a edición. México, D.F-Santa Fé de Bogotá: Editorial El Manual Moderno. 1997.
23. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
24. Haldane JBS. The estimation and significance of the logarithm of a ration of frequencies. Ann Hum Genet 1956; 20:309-311.
25. Gorodezky C. Métodos para el análisis estadístico del complejo HLA. Mexico, 2000. p.1-9.
26. Muller LP, Langner J, Schaaf A, Schonermarek U, Kujat G, Machulla H. Association of Chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients. Intern J Cancer 2001;92(2):203-207.
27. Khosravi F, Amirzargar AA, Danesh A, Sarrafnejad A. A preliminary study of HLA class I (A,B) and HLA class II (DRB) association in iranian patients with acute lymphoblastic leukemia. (abstrat). XIII International Congress of Histocompatibility and Immunogenetics. Seattle, WA, USA. Tissue Antigens. 2002;59 (Sup 2) p.18.
28. D'Amaro J, Bach F, Van Rood J, Rimms A, Bortin M. HLA associations with acute leukemia. Lancet 1984;1176-1178.
29. Bortin MM, D'Amaro J, Bach Fil, Rirnm AA, Van Rood JJ: HLA associations with leukaemia. Blood 1987;70:227-232.
30. Muller CA, Ilasmann R, Grosse Wildee FI: Significant association of acute lymphoblastic leukaemia with HLA-Cw7. Genet Epidemiol 1988; 5:453-461.
31. Villalobos C, Rivera S, Hassanhi M, Bermudez A, Montiel M, Marquez G, Nuñez J, Cipriani A. HLA by serology and molecular biology (PCR-SSP) in patients with leukaemia belonging to the Zulia State Blood Bank. XIII International Congress of Histocompatibility and Immunogenetics. Seattle, WA, USA. Tissue Antigens 2002; 59 (Sup 2) p.138
32. Klouda P, Lawler S, Till M, Hardisty R. Acute Lymphoblastic Leukaemia and HLA: A prospective study. Tissue Antigens 1994; 4:262-265.
33. Navarrete C, Alonso A, Awad J, McCloskey D, Ganesan T, Amess J, Lister A, Festenstein H. HLA class I and class II antigen associations in acute leukaemia. J Immunogen 1986; 13:77-84.
34. Amirzagar AA, Khosravi F, Sarrafnejad A. HLA class I (A,B) and HLA class II (DRB) associaction in iranian myieloid leukemia patients. XIII International Congress of Histocompatibility and Immunogenetics. Seattle, WA, USA. Tissue Antigens 2002; 59 (Sup 2) p.11.17.
35. Posthuma E, Falkenburg J, Apperley J, Gratwohl A, Hertenstein B, Schipper R, Oudshoorn M, Biezen J, Hermans J, Willemze R. HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Leukemia 2000; 14(5):859-862.
36. Layrisse Z, Guedez Y, Dominguez E, Herrera F, Soto M, Balbas O, Matos M, Alfonzo JC, Granados J, Scoroza J. Extended HLA haplotypes among the Bari Amerindians of the Perija Range. Relationship to other tribes based on four-loci haplotype frequencies. Hum Immunol 1995; 44:228-235.